6-K 1 d623547d6k.htm FORM 6-K Form 6-K
Table of Contents

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

Form 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

For the nine months ended September 30, 2013

 

 

Aegon N.V.

(Translation of registrant’s name into English)

 

 

Aegonplein 50

P.O. Box 85

2501 CB The Hague

The Netherlands

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

x  Form 20-F      ¨       Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):    ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):    ¨

 

 

 


Table of Contents

The financial statements, notes thereto and Operating and Financial Review and Prospects of Aegon N.V. listed below are attached hereto as Exhibit 99.1. Such financial statements and discussion and analysis are incorporated by reference herein and in Aegon’s Registration Statements under the Securities Act of 1933 on Form F-3 (Nos 333-178225, 333-178224, 333-174878, 333-155858, 333- 155857 and 333-150786) and on Form S-8 (Nos 333-89814, 333-129662, 333-132839, 333-132841, 333-138210, 333-144174, 333- 144175, 333-150774, 333-151983, 333-151984 and 333-157843).

Item 1: Interim Financial Statements

Condensed consolidated income statement for the nine months ended September 30, 2013 and September 30, 2012

Condensed consolidated statement of comprehensive income for the nine months ended September 30, 2013 and September 30, 2012

Condensed consolidated statement of financial position at September 30, 2013 and December 31, 2012

Condensed consolidated statement of changes in equity for the nine months ended September 30, 2013 and September 30, 2012

Condensed consolidated cash flow statement for the nine months ended September 30, 2013 and September 30, 2012

Notes to the condensed consolidated Interim financial statements

Item 2: Operating and financial review and prospects

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Aegon N.V.

(Registrant)

Date: November 7, 2013

/s/ J.H.P.M. van Rossum

J.H.P.M. van Rossum

Senior Vice President

Corporate Controller


Table of Contents

 

LOGO

Condensed Consolidated

Interim Financial Statements

Q3 2013

 

aegon.com    The Hague, November 7, 2013


Table of Contents

LOGO

 

Table of contents

 

Condensed consolidated income statement

     2   

Condensed consolidated statement of comprehensive income

     3   

Condensed consolidated statement of financial position

     4   

Condensed consolidated statement of changes in equity

     5   

Condensed consolidated cash flow statement

     6   

Notes to the condensed consolidated interim financial statements

     7   

 

 

 

 

 

Unaudited    1


Table of Contents

LOGO

 

Condensed consolidated income statement                
                                     

EUR millions

    Notes        Q3 2013        Q3 2012        YTD 2013        YTD 2012   
     

Premium income

    4        4,333        4,321        15,547        14,468   

Investment income

    5        1,877        2,264        5,938        6,492   

Fee and commission income

      475        457        1,442        1,370   

Other revenues

            2        1        6        6   

Total revenues

      6,687        7,043        22,933        22,336   

Income from reinsurance ceded

      806        1,104        2,170        3,128   

Results from financial transactions

    6        4,408        5,157        9,679        10,770   

Other income

    7        203        -        399        -   

Total income

      12,104        13,304        35,181        36,234   
     

Benefits and expenses

    8        11,649        12,688        33,849        34,339   

Impairment charges / (reversals)

    9        208        32        282        130   

Interest charges and related fees

      81        129        267        416   

Other charges

    10        18        1        135        19   

Total charges

      11,956        12,850        34,533        34,904   
     

Share in net result of joint ventures

      (3     (3     (6     (1

Share in net result of associates

            5        6        19        24   

Income before tax

      150        457        661        1,353   

Income tax (expense) / benefit

    11        77        (80     13        (202

Net income

            227        377        674        1,151   
     

Net income attributable to:

             

Equity holders of Aegon N.V.

      227        376        673        1,150   

Non-controlling interests

            -        1        1        1   
     

Earnings per share (EUR per share)

    18               

Basic earnings per common share

      0.08        0.17        0.23        0.50   

Basic earnings per common share B

      -        -        0.01        -   

Diluted earnings per common share

      0.08        0.17        0.23        0.50   

Diluted earnings per common share B

            -        -        0.01        -   

 

2    Unaudited


Table of Contents

LOGO

 

Condensed consolidated statement of comprehensive income

 

               
EUR millions   Q3 2013     Q3 2012     YTD 2013     YTD 2012  
     

Net income

    227        377        674        1,151   
     

Other comprehensive income:

           

Items that will not be reclassified to profit or loss:

           

Changes in revaluation reserve real estate held for own use

    (6     -        (5     3   

Remeasurements of defined benefit plans

    67        (79     356        (602

Income tax relating to items that will not be reclassified

    (31     9        (140     151   
     

Items that may be reclassified subsequently to profit or loss:

           

Gains / (losses) on revaluation of available-for-sale investments

    (571     2,107        (3,461     3,608   

(Gains) / losses transferred to the income statement on disposal and impairment of available-for-sale investments

    157        (115     -        (299

Changes in cash flow hedging reserve

    (64     (76     (375     40   

Movement in foreign currency translation and net foreign investment hedging reserve

    (481     (114     (510     329   

Equity movements of joint ventures

    3        19        (3     10   

Equity movements of associates

    42        3        49        22   

Income tax relating to items that may be reclassified

    166        (556     1,147        (974

Other

    -        1        (3     (4

Other comprehensive income for the period

    (718     1,199        (2,945     2,284   

Total comprehensive income

    (491     1,576        (2,271     3,435   
     

Total comprehensive income attributable to:

           

Equity holders of Aegon N.V.

    (488     1,575        (2,266     3,435   

Non-controlling interests

    (3     1        (5     -   

Amounts for 2012 have been restated for the changes in accounting policies as disclosed in note 2.

 

Unaudited    3


Table of Contents

LOGO

 

Condensed consolidated statement of financial position

 

 
            Sept. 30,
2013
    Dec. 31,
2012
 

EUR millions

    Notes                   
   

Assets

       

Intangible assets

    12        2,290        2,485   

Investments

    13        137,419        145,021   

Investments for account of policyholders

    14        161,165        152,968   

Derivatives

    15        14,455        21,134   

Investments in joint ventures

      1,431        1,568   

Investments in associates

      464        771   

Reinsurance assets

      11,062        11,965   

Deferred expenses and rebates

    17        12,038        11,644   

Other assets and receivables

      7,837        7,738   

Cash and cash equivalents

            6,133        9,590   

Total assets

      354,294        364,884   
   

Equity and liabilities

       

Shareholders’ equity

      20,332        23,488   

Other equity instruments

            4,996        5,018   

Issued capital and reserves attributable to equity holders of Aegon N.V.

      25,328        28,506  

Non-controlling interests

            8        13   

Group equity

      25,336        28,519   
   

Trust pass-through securities

      140        155   

Subordinated borrowings

      44        42   

Insurance contracts

      102,322        104,004   

Insurance contracts for account of policyholders

      81,285        76,169   

Investment contracts

      15,097        17,767   

Investment contracts for account of policyholders

      81,948        78,418   

Derivatives

    15        12,622        18,052   

Borrowings

    19        12,171        13,742   

Other liabilities

            23,329        28,016   

Total liabilities

 

            328,958        336,365   

Total equity and liabilities

            354,294        364,884   

Amounts for 2012 have been restated for the changes in accounting policies as disclosed in note 2.

 

4    Unaudited


Table of Contents

LOGO

 

Condensed consolidated statement of changes in equity

 

 
EUR millions   Share
capital 1
    Retained
earnings
    Revaluation
reserves
    Remeasurement
of defined
benefit plans
    Other
reserves
    Other equity
instruments
    Issued
capital and
reserves 2
   

Non-

controlling
interests

    Total  
       

Nine months ended September 30, 2013

                       
       

At beginning of year

    9,099        10,446        6,073        (1,085     (1,045     5,018        28,506        13        28,519   
       

Net income recognized in the income statement

    -        673        -        -        -        -        673        1        674   
       

Other comprehensive income:

                       

Items that will not be reclassified to profit or loss:

                       

Changes in revaluation reserve real estate held for own use

    -        -        (5     -        -        -        (5     -        (5

Remeasurements of defined benefit plans

    -        -        -        356        -        -        356        -        356   

Income tax relating to items that will not be reclassified

    -        -        1        (141     -        -        (140     -        (140
       

Items that may be reclassified subsequently to profit or loss:

                       

Gains / (losses) on revaluation of available-for-sale investments

    -        -        (3,461     -        -        -        (3,461     -        (3,461

Changes in cash flow hedging reserve

    -        -        (375     -        -        -        (375     -        (375

Movement in foreign currency translation and net foreign investment hedging reserves

    -        -        -        14        (524     -        (510     -        (510

Equity movements of joint ventures

    -        -        -        -        (3     -        (3     -        (3

Equity movements of associates

    -        -        -        -        49        -        49        -        49   

Disposal of group assets

    -        3        -        -        -        -        3        (3     -   

Income tax relating to items that may be reclassified

    -        -        1,136        -        11        -        1,147        -        1,147   

Transfer from / to other headings

    -        (3     3        -        -        -        -        -        -   

Other

    -        -        -        -        -        -        -        (3     (3

Total other comprehensive income

    -        -        (2,701     229        (467     -        (2,939     (6     (2,945

Total comprehensive income/ (loss) for 2013

    -        673        (2,701     229        (467     -        (2,266     (5     (2,271
       

Shares issued and withdrawn

    2        -        -        -        -        -        2        -        2   

Treasury shares

    -        (78     -        -        -        -        (78     -        (78

Dividends paid on common shares

    -        (240     -        -        -        -        (240     -        (240

Preferred dividend

    -        (83     -        -        -        -        (83     -        (83

Coupons on non-cumulative subordinated notes

    -        (15     -        -        -        -        (15     -        (15

Coupons on perpetual securities

    -        (105     -        -        -        -        (105     -        (105

Share options and incentive plans

    -        30        -        -        -        (22     8        -        8   

Repurchased and sold own shares

    (400     (1     -        -        -        -        (401     -        (401

At end of period

    8,701        10,627        3,372        (856     (1,512     4,996        25,328        8        25,336   
       

Nine months ended September 30, 2012

                       
       

At beginning of year (as previously stated)

    9,097        9,403        3,464        -        (964     4,720        25,720        14        25,734   
       

Changes in accounting policies relating to IFRS 10

    -        (122     -        -        -        -        (122     -        (122

Changes in accounting policies relating to IFRS 11

    -          17        -        (17     -        -        -        -   

Changes in accounting policies relating to IAS 19

    -        15        -        (979     -        -        (964     -        (964
       

At beginning of year, restated

    9,097        9,296        3,481        (979     (981     4,720        24,634        14        24,648   
       

Net income recognized in the income statement

    -        1,150        -        -        -        -        1,150        1        1,151   
       

Other comprehensive income:

                       

Items that will not be reclassified to profit or loss:

                       

Changes in revaluation reserve real estate held for own use

    -        -        3        -        -        -        3        -        3   

Remeasurements of defined benefit plans

    -        -        -        (602     -        -        (602     -        (602

Income tax relating to items that will not be reclassified

    -        -        (1     152        -        -        151        -        151   
       

Items that may be reclassified subsequently to profit or loss:

                       

Gains / (losses) on revaluation of available-for-sale investments

    -        -        3,608        -        -        -        3,608        -        3,608   

(Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments

    -        -        (299     -        -        -        (299     -        (299

Changes in cash flow hedging reserve

    -        -        40        -        -        -        40        -        40   

Movement in foreign currency translation and net foreign investment hedging reserves

    -        -        -        (13     342        -        329        -        329   

Equity movements of joint ventures

    -        -        -        -        10        -        10        -        10   

Equity movements of associates

    -        -        -        -        22        -        22        -        22   

Income tax relating to items that may be reclassified

    -        (6     (964     -        (4     -        (974     -        (974

Transfer from / to other headings

    -        (20     20        -        -        -        -        -        -   

Other

    -        (3     -        -        -        -        (3     (1     (4

Total other comprehensive income

    -        (29     2,407        (463     370        -        2,285        (1     2,284   

Total comprehensive income / (loss) for 2012

    -        1,121        2,407        (463     370        -        3,435        -        3,435   
       

Shares issued

    1        -        -        -        -        -        1        -        1   

Treasury shares

    -        2        -        -        -        -        2        -        2   

Dividends paid on common shares

    -        (148     -        -        -        -        (148     -        (148

Preferred dividend

    -        (59     -        -        -        -        (59     -        (59

Issuance of non-cumulative subordinated loans

    -        -        -        -        -        271        271        -        271   

Coupons on non-cumulative subordinated notes

    -        (17     -        -        -        -        (17     -        (17

Coupons on perpetual securities

    -        (130     -        -        -        -        (130     -        (130

Cost of issuance of non-cumulative subordinated notes (net of tax)

    -        (10     -        -        -        -        (10     -        (10

Share options and incentive plans

    -        -        -        -        -        20        20        -        20   

At end of period

    9,098        10,055        5,888        (1,442     (611     5,011        27,999        14        28,013   

1 For a breakdown of share capital please refer to note 18.

2 Issued capital and reserves attributable to equity holders of Aegon N.V.

Amounts for 2012 have been restated for the changes in accounting policies as disclosed in note 2.

 

Unaudited    5


Table of Contents

LOGO

 

 

Condensed consolidated cash flow statement

 

 
EUR millions   Q3 2013     Q3 2012  
   

Cash flow from operating activities

    (1,535     (1,101
   

Purchases and disposals of intangible assets

    (18     (30

Purchases and disposals of equipment and other assets

    (37     (41

Purchases, disposals and dividends of subsidiaries, associates and joint ventures

    590        (36

Cash flow from investing activities

    535        (107
   

Issuance and withdrawals of share capital

    (25     1   

Dividends paid

    (323     (207

Repurchased and sold own shares

    (401     -   

Issuances, repurchases and coupons of perpetuals

    (140     (173

Issuances, repurchases and coupons of non-cumulative subordinated notes

    (20     249   

Issuances and repayments of borrowings

    (1,508     1,157   

Cash flow from financing activities

    (2,417     1,027   
   

Net increase / (decrease) in cash and cash equivalents

    (3,417     (181

Net cash and cash equivalents at January 1

    9,497        7,717   

Effects of changes in foreign exchange rates

    (56     66   

Net cash and cash equivalents at end of period

    6,024        7,602   
   
     Sept. 30,
2013
    Sept. 30,
2012
 

Cash and cash equivalents

    6,133        7,718   

Bank overdrafts

    (109     (116

Net cash and cash equivalents

    6,024        7,602   

Amounts for 2012 have been restated for the changes in accounting policies as disclosed in note 2.

 

6    Unaudited


Table of Contents

LOGO

 

Notes to the Condensed Consolidated Interim Financial Statements

Amounts in EUR millions, unless otherwise stated

Aegon N.V., incorporated and domiciled in the Netherlands, is a public limited liability company organized under Dutch law and recorded in the Commercial Register of The Hague under number 27076669 and with its registered address at Aegonplein 50, 2591 TV, The Hague, the Netherlands. Aegon N.V. serves as the holding company for the Aegon Group and has listings of its common shares in Amsterdam and New York.

Aegon N.V. (or “the company”) and its consolidated subsidiaries (“Aegon” or “the Group”) have life insurance and pensions operations in over twenty countries in the Americas, Europe and Asia and are also active in savings and asset management operations, accident and health insurance, general insurance and to a limited extent banking operations. Its headquarters are located in The Hague, the Netherlands. The Group employs over 23,000 people worldwide.

1. Basis of presentation

The Condensed Consolidated Interim Financial Statements as at, and for the nine month period ended, September 30, 2013, have been prepared in accordance with IAS 34 “Interim Financial Reporting”, as adopted by the European Union (hereafter “IFRS”). They do not include all of the information required for a full set of financial statements prepared in accordance with IFRS and should therefore be read together with the 2012 consolidated financial statements of Aegon N.V. as included in Aegon’s Annual Report for 2012. Aegon’s Annual Report for 2012 is available on its website (aegon.com).

The Condensed Consolidated Interim Financial Statements have been prepared in accordance with the historical cost convention as modified by the revaluation of investment properties and those financial instruments (including derivatives) and financial liabilities that have been measured at fair value. Certain amounts in prior periods have been reclassified to conform to the current year presentation. These reclassifications had no effect on net income, shareholders’ equity or earnings per share. The Condensed Consolidated Interim Financial Statements as at, and for the nine months ended, September 30, 2013, were approved by the Executive Board on November 6, 2013.

The published figures in these Condensed Consolidated Interim Financial Statements are unaudited.

2. Significant accounting policies

The accounting policies and methods of computation applied in the Condensed Consolidated Interim Financial Statements are the same as those applied in the 2012 consolidated financial statements, except for the newly applied accounting policies.

Adoption of new accounting policies

Aegon applies new and amended standards that require restatement of previous financial statements. These include IFRS 10 “Consolidated Financial Statements”, IFRS 11 “Joint Arrangements”, IAS 19 (revised 2011) “Employee Benefits” and IAS 1 “Presentation of Financial Statements”. Application of IFRS 13 “Fair Value Measurement” is required prospectively as of the beginning of the annual reporting period.

The nature and the impact of each new standard/amendment that has been applied for the first time in 2013 is described below:

 

t  

IFRS 7, “Financial Instruments: Disclosures – Offsetting Financial Assets and Financial Liabilities”: The amendments to IFRS 7 enable users of the financial statements to evaluate the effect or potential effect of netting arrangements, including rights of set-off associated with the entity’s recognized financial assets and recognized financial liabilities, on the entity’s financial position. The amendment affects disclosure only and is included in note 20.

 

Unaudited    7


Table of Contents

LOGO

 

t  

IFRS 10, “Consolidated Financial Statements”: IFRS 10 replaces all the guidance on control and consolidation in IAS 27, “Consolidated and Separate Financial Statements”, and SIC-12, “Consolidation – Special Purpose Entities”. The application of this new standard impacted the financial position of Aegon by consolidating one securitization vehicle that was previously not consolidated. In addition, for several investment funds the consolidation conclusion has been revisited, resulting in changes compared to previous years. The impact of the adoption of IFRS 10 on the financial position of Aegon is described in note 2.1.

t  

IFRS 11, “Joint Arrangements”: IFRS 11 replaces IAS 31, “Interests in Joint Ventures” and SIC-13, “Jointly-controlled Entities — Non-monetary Contributions by Venturers”. IFRS 11 removes the option to account for jointly controlled entities (JCEs) using proportionate consolidation. Instead, JCEs that meet the definition of a joint venture under IFRS 11 must be accounted for using the equity method. The effect of this standard is that Aegon starts to account for its joint ventures on a net equity value basis. The impact of the adoption of IFRS 11 on the financial position of Aegon is described in note 2.1.

t  

IFRS 12, “Disclosure of Interests in Other Entities”: IFRS 12 imposes disclosure requirements on interests in subsidiaries, associates, joint ventures, and structured entities. This standard affects disclosure only and has therefore no impact on Aegon’s financial position or performance. Aegon will provide the disclosures in the Annual Report 2013 as required.

t  

IFRS 13, “Fair Value Measurement”: IFRS 13 establishes a single source of guidance under IFRS for all fair value measurements. IFRS 13 does not change when an entity is required to use fair value, but rather provides guidance on how to measure fair value under IFRS when fair value is required or permitted. The application of IFRS 13 has not impacted the fair value measurements carried out by the Group, which are described in note 2.3. IFRS 13 also requires specific disclosures on fair values, some of which replace existing disclosure requirements in other standards, including IFRS 7, “Financial Instruments: Disclosures”. Some of these disclosures, specifically for financial instruments, are required in interim condensed consolidated financial statements. Aegon provides these disclosures in note 16.

t  

IAS 1, “Financial Statement Presentation – Presentation of Items of Other Comprehensive Income”: The amendments require the grouping of items within other comprehensive income that may be reclassified to the profit or loss section of the income statement. The amendments also reaffirm existing requirements that items in other comprehensive income and profit or loss should be presented as either a single statement or two consecutive statements. The amendment affects presentation only and changes are included in the condensed statement of comprehensive income.

t  

IAS 19, “Employee Benefits”: The revised standard eliminates the option to defer the recognition of actuarial gains and losses, known as the “corridor method”. The amendments streamline the presentation of changes in assets and liabilities arising from defined benefit plans, including requiring remeasurements to be presented in other comprehensive income, to immediately recognize all past service costs and to replace interest cost and expected return on plan assets with a net interest amount that is calculated by applying the discount rate to the net defined benefit liability (asset). The impact of the adoption of the revised IAS 19 on the financial position of Aegon is described in note 2.2.

t  

IAS 27, “Separate Financial Statements”: IAS 27 was amended following the issuance of IFRS 10. The revised IAS 27 deals only with the accounting for subsidiaries, associates and joint ventures in the separate financial statements of the parent company. The application of the amendments has not impacted the financial position of the Group.

t  

IAS 28, “Investments in Associates and Joint Ventures”: IAS 28 was amended following the issuance of IFRS 10 and IFRS 11. The revised IAS 28 describes the application of the equity method to investments in joint ventures in addition to associates. The application of the amendments has not impacted the financial position of the Group.

For a complete overview of IFRS standards, published before January 1, 2013, that will be applied in future years, but were not early adopted by the Group, please refer to Aegon’s Annual Report for 2012.

Taxes

Taxes on income for the nine months interim period, ending September 30, 2013, are accrued using the tax rate that would be applicable to expected total annual earnings.

 

8    Unaudited


Table of Contents

LOGO

 

Judgments and critical accounting estimates

Preparing the Condensed Consolidated Interim Financial Statements requires management to make judgments, estimates and assumptions, including the likelihood, timing or amount of future transactions or events, that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from the estimates made.

In preparing the Condensed Consolidated Interim Financial Statements, significant judgments made by management in applying the Group’s accounting policies and the key sources of estimation uncertainty were the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2012, except for the newly applied assumption changes.

Assumptions changes

In third quarter of 2013, to reflect the low interest rate environment, Aegon lowered its long-term assumption for 10-year US Treasury yields by 50 basis points to 4.25% and extended the uniform grading period from 5 years to 10 years. Aegon also changed its assumed returns for US separate account bond fund to 4% over the next 10 years and 6% thereafter from its previous assumptions of 4% over the next 5 years and 6% thereafter. In addition, Aegon changed its long-term equity market return assumption for the estimated gross profit in variable life and variable annuity products in the Americas from 9% to 8%. In total, these assumption changes led to a negative impact on earnings of EUR 405 million in the third quarter of 2013. Both the assumptions for the bond fund and that for the long-term equity market are gross assumptions from which asset management and policy fees are deducted to determine the policyholder return.

Exchange rates

Assets and liabilities are translated at the closing rates on the balance sheet date. Income, expenses and capital transactions (such as dividends) are translated at average exchange rates or at the prevailing rates on the transaction date, if more appropriate. The following exchange rates are applied for the Condensed Consolidated Interim Financial Statements:

Closing exchange rates

 

                         USD         GBP   

September 30, 2013

     1         EUR         1.3537         0.8359   

December 31, 2012

     1         EUR         1.3184         0.8111   

Weighted average exchange rates

 

                         USD         GBP   

Q3 2013

     1         EUR         1.3161         0.8512   

Q3 2012

     1         EUR         1.2811         0.8115   

Other

Aegon N.V. is subject to legal restrictions on the amount of dividends it can pay to its shareholders. Under Dutch law, the amount that is available to pay dividends consists of total shareholders’ equity less the issued and outstanding capital and less the reserves required by law. The revaluation account and legal reserves, foreign currency translation reserve and other reserves, cannot be freely distributed. In case of negative balances for individual reserves legally to be retained, no distributions can be made out of retained earnings to the level of these negative amounts.

 

Unaudited    9


Table of Contents

LOGO

 

In addition, Aegon’s subsidiaries, principally insurance companies, are subject to restrictions on the amounts of funds they may transfer in the form of cash dividends or otherwise to their parent companies. There can be no assurance that these restrictions will not limit or restrict Aegon in its ability to pay dividends in the future.

2.1 Changes in accounting policies for consolidation and joint arrangements

Aegon has early adopted IFRS 10 – “Consolidated Financial Statements” on January 1, 2013. Aegon also adopted IFRS 11, “Joint Arrangements”, IFRS 12, “Disclosure of Interests in Other Entities”, and consequential amendments to IAS 27, “Separate Financial Statements” and IAS 28, “Investments in Associates and Joint Ventures”, at the same time.

a. Subsidiaries

IFRS 10 changes the definition of control such that an investor controls an investee when it is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. To meet the definition of control in IFRS 10, all three criteria must be met, including: (a) an investor has power over an investee; (b) the investor has exposure, or rights, to variable returns from its involvement with the investee; and (c) the investor has the ability to use its power over the investee to affect the amount of the investor’s returns.

Aegon has applied the new standard retrospectively, in accordance with the transitional provisions of IFRS 10. The application of this new standard impacted the financial position of Aegon by consolidating one securitization vehicle that was previously not consolidated. In addition, for several investment funds the consolidation conclusion has been revisited which resulted in changes compared to previous years. The effect of the change in accounting policies for consolidation on the financial position, comprehensive income and the cash flows of Aegon at January 1, 2012, and December 31, 2012, are summarized together with the impact of IFRS 11 and revised IAS 19 in note 2.4.

b. Joint arrangements

IFRS 11 replaces IAS 31 “Interests in Joint Ventures” and SIC-13 “Jointly-controlled Entities — Non-monetary Contributions by Venturers”. IFRS 11 removes the option to account for jointly controlled entities (JCEs) using proportionate consolidation. Instead, JCEs that meet the definition of a joint venture under IFRS 11 must be accounted for using the equity method.

In general, joint arrangements are contractual agreements whereby the Group undertakes with other parties an economic activity that is subject to joint control. Joint control exists when it is contractually agreed to share control of an economic activity. Joint control exists only when decisions about the relevant activities require the unanimous consent of the parties sharing control.

Aegon has early adopted IFRS 11 - “Joint Arrangements”, on January 1, 2013. Under IFRS 11 investments in joint arrangements are classified as either joint operations or joint ventures depending on the contractual rights and obligations each investor has rather than the legal structure of the joint arrangement. Aegon has assessed the nature of its joint arrangements and determined them to be joint ventures. The joint ventures will be accounted for using the equity method and are no longer proportionately consolidated.

Aegon has applied the new policies for interests in joint ventures occurring on or after January 1, 2012, in accordance with the transition provisions of IFRS 11. The effects of the change in accounting policies for joint arrangements on the financial position of the Group are summarized in note 2.4.

 

10    Unaudited


Table of Contents

LOGO

 

2.2 Changes in accounting policies for assets and liabilities relating to employee benefits

Aegon adopted IAS 19 - “Employee Benefits”, on January 1, 2013. As a result, Aegon changed its accounting policies for the assets and liabilities relating to employee benefits.

Aegon has applied the new policies for employee benefits retrospectively in accordance with the transitional provisions of the revised IAS 19. Aegon’s accounting policies for assets and liabilities relating to employee benefits as set out below reflect the changes under the revised IAS 19.

a. Short-term employee benefits

Prior to January 1, 2013, short-term benefits were recognized based on the employee’s entitlement to the benefits. Under the revised IAS 19 a liability is recognized for the undiscounted amount of short-term employee absences benefits expected to be settled within one year after the end of the period in which the service was rendered. Accumulating short-term absences are recognized over the period in which the service is provided. Benefits that are not service-related are recognized when the event that gives rise to the obligation occurs. This change in accounting policies has no impact on Aegon’s financial position.

b. Post-employment benefits

The Group has issued defined contribution plans and defined benefit plans. A plan is classified as a defined contribution plan when the Group has no further obligation than the payment of a fixed contribution. All other plans are classified as defined benefit plans.

Defined contribution plans

The contribution payable to a defined contribution plan for services provided is recognized as an expense in the income statement. An asset is recognized to the extent that the contribution paid exceeds the amount due for services provided.

Defined benefit plans

Revised IAS 19 includes a number of amendments to the accounting for defined benefit plans, including actuarial gains and losses that are recognized in other comprehensive income and permanently excluded from profit and loss; expected returns on plan assets that are no longer recognized in profit or loss. Instead, there is a requirement to recognize interest on the net defined benefit liability (asset) in profit or loss, calculated using the discount rate used to measure the defined benefit obligation, and; unvested past service costs are recognized in profit or loss at the earlier of when the amendment occurs or when the related restructuring or termination costs are recognized. Other amendments include new disclosures, such as quantitative sensitivity disclosures.

Upon transition to revised IAS 19, Aegon recognizes all actuarial gains and losses as they occur and therefore no longer applies the corridor approach. Furthermore, past service costs are recognized immediately if the benefits have vested directly after the introduction of, or changes to, a pension plan.

The effects of the change in accounting policies for assets and liabilities relating to employee benefits on the financial position of the Group are summarized in note 2.4.

 

Unaudited    11


Table of Contents

LOGO

 

2.3 Changes in accounting policies for fair value measurement relating to financial and non-financial assets and liabilities

Aegon adopted IFRS 13 – “Fair Value Measurement”, on January 1, 2013. This resulted in the Group changing its accounting policies for the fair value measurement of financial and non-financial assets and liabilities.

IFRS 13 establishes a single source of guidance under IFRS for all fair value measurements. IFRS 13 does not change when an entity is required to use fair value, but rather provides guidance on how to measure fair value under IFRS when fair value is required or permitted. Under IFRS 13, fair value is defined as the amount that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions (i.e. an exit price at the measurement date from the perspective of a market participant that holds the asset or owes the liability). A fair value measurement assumes that the transaction to sell the asset or transfer the liability takes place either:

(a) in the principal market for the asset or liability; or

(b) in the absence of a principal market, in the most advantageous market for the asset or liability.

The application of IFRS 13 has not impacted Aegon’s fair value measurements. The description of Aegon’s methods of determining fair value is included in the consolidated financial statements 2012 and has not changed under IFRS 13. IFRS 13 requires specific disclosures on fair values, some of which replace existing disclosure requirements in other standards, including IFRS 7 Financial Instruments: Disclosures. Some of these disclosures, specifically for financial instruments, are required in interim condensed consolidated financial statements. These disclosures are provided in note 16.

 

12    Unaudited


Table of Contents

LOGO

 

2.4 Impact of changes in accounting policies on the financial position

 

Impact of changes in accounting policies on condensed consolidated income statement

 

 
     YTD 2012
(previously
reported)
    Change in
accounting
policy
IFRS 10/11
    Change in
accounting
policy
IAS 19
    YTD 2012
(restated)
 
EUR millions                            
   

Total income

    36,756        (522     -        36,234   
   

Total charges

    (35,426     471        51        (34,904
   

Share in net result of joint ventures

    -        (1     -        (1

Share in net result of associates

    24        -        -        24   

Income before tax

    1,354        (52     51        1,353   

Income tax (expense) / benefit

    (205     20        (17     (202

Net income

    1,149        (32     34        1,151   

Net income attributable to:

         

Equity holders of Aegon N.V.

    1,148        (32     34        1,150   

Non-controlling interests

    1        -        -        1   
   

Earnings per share (EUR per share)

         

Basic earnings per share

    0.50        (0.02     0.02        0.50   

Diluted earnings per share

    0.50        (0.02     0.02        0.50   
   

Earnings per common share calculation

         

Net income attributable to equity holders of Aegon N.V.

    1,148        (32     34        1,150   

Preferred dividend

    (59     -        -        (59

Coupons on other equity instruments

    (146     -        -        (146

Earnings attributable to common shareholders

    943        (32     34        945   
   

Weighted average number of common shares outstanding (in million)

    1,895        -        -        1,895   

 

Impact of changes in accounting policies on condensed consolidated statement of comprehensive income

 

 
     YTD 2012
(previously
reported)
    Change in
accounting
policy
IFRS 10/11
    Change in
accounting
policy
IAS 19
    YTD 2012
(restated)
 
EUR millions                            

Net income

    1,149        (32     34        1,151   
   

Items that will not be reclassified to profit or loss:

         

Changes in revaluation reserve real estate held for own use

    3        -        -        3   

Remeasurements of defined benefit plans

    -        -        (602     (602

Income tax relating to items that will not be reclassified

    -        (1     152        151   
   

Items that may be reclassified to profit or loss:

         

Gains / (losses) on revaluation of available-for-sale investments

    3,628        (20     -        3,608   

Changes in cash flow hedging reserve

    35        5          40   

Income tax relating to items that may be reclassified

    (981     7        -        (974

Disposal of group assets

         

Movement in foreign currency translation and net foreign investment hedging reserves

    341        1        (13     329   

Equity movements of joint ventures

    -        10        -        10   

Other comprehensive income for the period

    (279     (2     -        (281

Total other comprehensive income for the period

    2,747        -        (463     2,284   

Total comprehensive income

    3,896        (32     (429     3,435   
   

Total comprehensive income attributable to:

         

Equity holders of Aegon N.V.

    3,896        (32     (429     3,435   

Non-controlling interests

    -        -        -        -   

 

Unaudited    13


Table of Contents

LOGO

 

Impact of changes in accounting policies on condensed consolidated statement of financial position

 

 
     January 1,
2012
(previously
reported)
    Change in
accounting
policy
IFRS 10/11
    Change in
accounting
policy
IAS 19
    January 1,
2012
(restated)
    December 31,
2012
(previously
reported)
    Change in
accounting
policy
IFRS 10/11
    Change in
accounting
policy
IAS 19
    December 31,
2012
(restated)
 
EUR millions                                                        
   

Assets

                 

Investments

    144,079        (1,374     -        142,705        146,234        (1,213     -        145,021   

Investments for account of policyholders

    142,529        (866     -        141,663        153,670        (702     -        152,968   

Investments in joint ventures

    -        1,224        -        1,224        -        1,568        -        1,568   

Defined benefit assets

    303        -        (285     18        201        -        (179     22   

Other assets

    58,465        (299     -        58,166        66,013        (708     -        65,305   

Total assets

    345,376        (1,315     (285     343,776        366,118        (1,055     (179     364,884   
   

Equity and liabilities

                 

Shareholders’ equity

    21,000        (122     (964     19,914        24,669        (154     (1,027     23,488   

Other equity instruments

    4,720        -        -        4,720        5,018        -        -        5,018   

Issued capital and reserves attributable to equity holders of Aegon N.V.

    25,720        (122     (964     24,634        29,687        (154     (1,027     28,506  

Non-controlling interests

    14        -        -        14        13        -        -        13   

Group equity

    25,734        (122     (964     24,648        29,700        (154     (1,027     28,519   
   

Insurance contracts

    104,974        (1,452     -        103,522        105,209        (1,205     -        104,004   

Insurance contracts for account of policyholders

    73,425        (866     -        72,559        76,871        (702     -        76,169   

Investment contracts

    20,847        (1     -        20,846        17,768        (1     -        17,767   

Investment contracts for account of policyholders

    71,433        -        -        71,433        78,418        -        -        78,418   

Defined benefit obligations

    2,184        -        1,147        3,331        2,222        -        1,328        3,550   

Deferred tax liabilities

    2,499        (27     (468     2,004        3,622        (33     (480     3,109   

Other liabilities

    44,280        1,153        -        45,433        52,308        1,040        -        53,348   

Total liabilities

 

    319,642        (1,193     679        319,128        336,418        (901     848        336,365   

Total equity and liabilities

    345,376        (1,315     (285     343,776        366,118        (1,055     (179     364,884   
                 
               

Impact of changes in accounting policies on condensed consolidated statement of changes in equity

 

 
     September 30,
2012
(previously
reported)
    Change in
accounting
policy
IFRS 10/11
    Change in
accounting
policy
IAS 19
    September 30,
2012
(restated)
    December 31,
2012
(previously
reported)
    Change in
accounting
policy
IFRS 10/11
    Change in
accounting
policy
IAS 19
    December 31,
2012
(restated)
 
EUR millions                                                        
   

Share capital

    9,098        -        -        9,098        9,099        -        -        9,099   

Retained earnings

    10,162        (156     49        10,055        10,543        (155     58        10,446   

Revaluation reserves

    5,880        8        -        5,888        6,082        (9     -        6,073   

Remeasurement of defined benefit plans

    -        -        (1,442     (1,442     -        -        (1,085     (1,085

Other reserves

    (605     (6     -        (611     (1,055     10        -        (1,045

Shareholders’ equity

    24,535        (154     (1,393     22,988        24,669        (154     (1,027     23,488   

 

Impact of changes in accounting policies on condensed consolidated cash flow statement

 

  

     Q3 2012
(previously
reported)
    Change in
accounting
policy
IFRS 10/11
    Change in
accounting
policy
IAS 19
    Q3 2012
(restated)
 

EUR millions

                               

 

Cash flow from operating activities

    (1,124     23        -        (1,101

 

Cash flow from investing activities

    (159     52        -        (107

 

Cash flow from financing activities

    1,084        (57     -        1,027   

 

Net increase / (decrease) in cash and cash equivalents

    (199     18        -        (181

Net cash and cash equivalents at January 1

    7,826        (109     -        7,717   

Effects of changes in foreign exchange rates

    67        (1     -        66   

Net cash and cash equivalents at end of period

    7,694        (92     -        7,602   
   
     September 30,
2012
(previously
reported)
    Change in
accounting
policy
IFRS 10/11
    Change in
accounting
policy
IAS 19
    September 30,
2012
(restated)
 
   

Cash and cash equivalents

    7,810        (92     -        7,718   

Bank overdrafts

    (116     -        -        (116

Net cash and cash equivalents

    7,694        (92     -        7,602   

 

14    Unaudited


Table of Contents

LOGO

 

3. Segment information

3.1 Income statement

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    New
Markets
    Holding and
other
activities
    Eliminations     Segment
Total
    Joint
ventures and
associates
eliminations
    Consolidated  

Three months ended September 30, 2013

                   
     

Underlying earnings before tax geographically

    371        85        26        74        (25     -        531        (17     514   

Fair value items

    (502     14        (8     (12     15        -        (493     4        (489

Realized gains / (losses) on investments

    7        190        9        (4     -        -        202        2        204   

Impairment charges

    (43     (13     (12     (4     -        -        (72     -        (72

Impairment reversals

    27        -        -        -        -        -        27        -        27   

Other income / (charges)

    90        (2     (1     (124     (5     -        (42     7        (35

Run-off businesses

    1        -        -        -        -        -        1        -        1   

Income before tax

    (49     274        14        (70     (15     -        154        (4     150   

Income tax (expense) / benefit

    56        (84     89        6        6        -        73        4        77   

Net income

    7        190        103        (64     (9     -        227        -        227   

Inter-segment underlying earnings

    (42     (15     (14     65        6             
     

Revenues

                   

Life insurance gross premiums

    1,550        431        1,487        304        -        (18     3,754        (96     3,658   

Accident and health insurance

    455        41        -        41        2        (2     537        (2     535   

General insurance

    -        104        -        55        -        -        159        (19     140   

Total gross premiums

    2,005        576        1,487        400        2        (20     4,450        (117     4,333   

Investment income

    832        587        413        54        84        (83     1,887        (10     1,877   

Fee and commission income

    314        78        12        150        -        (59     495        (20     475   

Other revenues

    1        -        -        1        1        -        3        (1     2   

Total revenues

    3,152        1,241        1,912        605        87        (162     6,835        (148     6,687   

Inter-segment revenues

    5        1        -        72        84                                   

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    New
Markets
    Holding and
other
activities
    Eliminations     Segment
Total
    Joint
ventures and
associates
eliminations
    Consolidated  

Three months ended September 30, 2012

                   
     

Underlying earnings before tax geographically

    362        85        27        70        (50     -        494        (23     471   

Fair value items

    (45     (53     (17     (1     (26     -        (142     17        (125

Realized gains / (losses) on investments

    69        40        14        5        -        -        128        (4     124   

Impairment charges

    (44     (13     -        (5     -        -        (62     7        (55

Impairment reversals

    27        -        -        -        -        -        27        -        27   

Other income / (charges)

    (1     (3     15        (8     -        -        3        -        3   

Run-off businesses

    12        -        -        -        -        -        12        -        12   

Income before tax

    380        56        39        61        (76     -        460        (3     457   

Income tax (expense) / benefit

    (77     (4     -        (23     21        -        (83     3        (80

Net income

    303        52        39        38        (55     -        377        -        377   

Inter-segment underlying earnings

    (49     (14     (15     71        7             
     

Revenues

                   

Life insurance gross premiums

    1,643        405        1,445        292        -        (18     3,767        (142     3,625   

Accident and health insurance

    476        34        -        43        1        (1     553        (1     552   

General insurance

    -        107        -        37        -        -        144        -        144   

Total gross premiums

    2,119        546        1,445        372        1        (19     4,464        (143     4,321   

Investment income

    927        572        728        79        90        (93     2,303        (39     2,264   

Fee and commission income

    282        79        37        138        -        (67     469        (12     457   

Other revenues

    2        -        -        1        1        -        4        (3     1   

Total revenues

    3,330        1,197        2,210        590        92        (179     7,240        (197     7,043   

Inter-segment revenues

    7        -        -        79        93                                   

 

Unaudited    15


Table of Contents

LOGO

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    New
Markets
    Holding and
other
activities
    Eliminations     Segment
Total
    Joint
ventures and
associates
eliminations
    Consolidated  

Nine months ended September 30, 2013

                   
     

Underlying earnings before tax geographically

    1,043        244        77        188        (97     (1     1,454        (42     1,412   

Fair value items

    (881     (95     (11     (23     (39     -        (1,049     32        (1,017

Realized gains / (losses) on investments

    84        276        38        (1     -        -        397        1        398   

Impairment charges

    (98     (35     (28     (10     -        -        (171     -        (171

Impairment reversals

    52        -        -        -        -        -        52        -        52   

Other income / (charges)

    84        (29     (47     (22     (5     -        (19     6        (13

Run-off businesses

    -        -        -        -        -        -        -        -        -   

Income before tax

    284        361        29        132        (141     (1     664        (3     661   

Income tax (expense) / benefit

    3        (93     88        (23     35        -        10        3        13   

Net income

    287        268        117        109        (106     (1     674        -        674   

Inter-segment underlying earnings

    (131     (43     (43     196        21             
     

Revenues

                   

Life insurance gross premiums

    4,641        3,062        5,033        1,023        1        (56     13,704        (341     13,363   

Accident and health insurance

    1,351        213        -        136        6        (6     1,700        (10     1,690   

General insurance

    -        382        -        137        -        -        519        (25     494   

Total gross premiums

    5,992        3,657        5,033        1,296        7        (62     15,923        (376     15,547   

Investment income

    2,528        1,684        1,595        179        255        (255     5,986        (48     5,938   

Fee and commission income

    942        241        68        425        -        (180     1,496        (54     1,442   

Other revenues

    4        -        -        2        3        -        9        (3     6   

Total revenues

    9,466        5,582        6,696        1,902        265        (497     23,414        (481     22,933   

Inter-segment revenues

    15        1        1        221        259                                   

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    New
Markets
    Holding and
other
activities
    Eliminations     Segment
Total
    Joint
ventures and
associates
eliminations
    Consolidated  

Nine months ended September 30, 2012

                   
     

Underlying earnings before tax geographically

    1,014        240        83        222        (167     (2     1,390        (54     1,336   

Fair value items

    (60     115        (20     (6     59        -        88        38        126   

Realized gains / (losses) on investments

    132        68        48        10        -        -        258        (4     254   

Impairment charges

    (137     (19     -        (9     (4     2        (167     7        (160

Impairment reversals

    51        -        -        -        -        (2     49        -        49   

Other income / (charges)

    (3     (272     34        (26     (1     -        (268     (1     (269

Run-off businesses

    17        -        -        -        -        -        17        -        17   

Income before tax

    1,014        132        145        191        (113     (2     1,367        (14     1,353   

Income tax (expense) / benefit

    (203     17        (10     (68     48        -        (216     14        (202

Net income

    811        149        135        123        (65     (2     1,151        -        1,151   

Inter-segment underlying earnings

    (142     (47     (47     214        22             
     

Revenues

                   

Life insurance gross premiums

    4,839        2,587        4,432        1,048        -        (52     12,854        (568     12,286   

Accident and health insurance

    1,376        186        -        147        3        (3     1,709        (10     1,699   

General insurance

    -        375        -        108        -        -        483        -        483   

Total gross premiums

    6,215        3,148        4,432        1,303        3        (55     15,046        (578     14,468   

Investment income

    2,747        1,715        1,917        254        278        (280     6,631        (139     6,492   

Fee and commission income

    861        245        103        395        -        (201     1,403        (33     1,370   

Other revenues

    3        -        -        2        4        -        9        (3     6   

Total revenues

    9,826        5,108        6,452        1,954        285        (536     23,089        (753     22,336   

Inter-segment revenues

    23        -        1        233        279                                   

Non-IFRS measures

For segment reporting purposes the following non-IFRS financial measures are included: underlying earnings before tax, income tax and income before tax. These non-IFRS measures are calculated by consolidating on a proportionate basis Aegon’s joint ventures and associated companies. Aegon believes that its non-IFRS measures provide meaningful information about the underlying results of Aegon’s business, including insight into the financial measures that Aegon’s senior management uses in managing the business.

Among other things, Aegon’s senior management is compensated based in part on Aegon’s results against targets using the non-IFRS measures presented here. While many other insurers in Aegon’s peer group present substantially similar non-IFRS measures, the non-IFRS measures presented in this document may nevertheless differ from the non-IFRS measures presented by other insurers. There is no standardized meaning to these measures under IFRS or any other recognized set of accounting standards. Readers are cautioned to consider carefully the different ways in which Aegon and its peers present similar information before comparing them.

 

16    Unaudited


Table of Contents

LOGO

 

Aegon believes the non-IFRS measures shown herein, when read together with Aegon’s reported IFRS financial statements, provide meaningful supplemental information for the investing public to evaluate Aegon’s business after eliminating the impact of current IFRS accounting policies for financial instruments and insurance contracts, which embed a number of accounting policies alternatives that companies may select in presenting their results (i.e. companies can use different local GAAPs to measure the insurance contract liability) and that can make the comparability from period to period difficult.

The reconciliation from underlying earnings before tax to income before tax, being the most comparable IFRS measure, is presented in the tables in this note.

Underlying earnings

Certain assets held by Aegon Americas, Aegon the Netherlands and Aegon United Kingdom are carried at fair value and managed on a total return basis, with no offsetting changes in the valuation of related liabilities. These include assets such as investments in hedge funds, private equities, real estate (limited partnerships), convertible bonds and structured products. Underlying earnings exclude any over- or underperformance compared to management’s long-term expected return on assets.

Based on current holdings and asset returns, the long-term expected return on an annual basis is 8-10%, depending on asset class, including cash income and market value changes. The expected earnings from these asset classes are net of deferred policy acquisition costs (DPAC) where applicable.

In addition, certain products offered by Aegon Americas contain guarantees and are reported on a fair value basis, including the segregated funds offered by Aegon Canada and the total return annuities and guarantees on variable annuities of Aegon USA. The earnings on these products are impacted by movements in equity markets and risk-free interest rates. Short-term developments in the financial markets may therefore cause volatility in earnings. Included in underlying earnings is a long-term expected return on these products and excluded is any over- or underperformance compared to management’s expected return. The fair value movements of certain guarantees and the fair value change of derivatives that hedge certain risks on these guarantees of Aegon the Netherlands and Variable Annuities Europe (included in New Markets) are excluded from underlying earnings, and the long-term expected return for these guarantees is set at zero.

Holding and other activities include certain issued bonds that are held at fair value through profit or loss (FVTPL). The interest rate risk on these bonds is hedged using swaps. The fair value movement resulting from changes in Aegon’s credit spread used in the valuation of these bonds are excluded from underlying earnings and reported under fair value items.

Fair value items

Fair value items include the over- or underperformance of investments and guarantees held at fair value for which the expected long-term return is included in underlying earnings. Changes to these long-term return assumptions are also included in the fair value items.

In addition, hedge ineffectiveness on hedge transactions, fair value changes on economic hedges without natural offset in earnings and for which no hedge accounting is applied and fair value movements on real estate are included under fair value items.

Realized gains or losses on investments

Includes realized gains and losses on available-for-sale investments, mortgage loans and other loan portfolios.

Impairment charges/reversals

Includes impairments and reversals on available-for-sale debt securities and impairments on shares including the effect of deferred policyholder acquisition costs, mortgage loans and loan portfolios on amortized cost and associates respectively.

 

Unaudited    17


Table of Contents

LOGO

 

Other income or charges

Other income or charges is used to report any items which cannot be directly allocated to a specific line of business. Also items that are outside the normal course of business are reported under this heading.

Other charges include restructuring charges that are considered other charges for segment reporting purposes because they are outside the normal course of business. In the condensed consolidated income statement, these charges are included in operating expenses.

Run-off businesses

Includes underlying results of business units where management has decided to exit the market and to run-off the existing block of business. Currently, this line includes the run-off of the institutional spread-based business, structured settlements blocks of business, Bank-Owned and Corporate-Owned Life Insurance (BOLI/COLI) business, and the sale of the life reinsurance business in the United States. Aegon has other blocks of business for which sales have been discontinued and of which the earnings are included in underlying earnings.

Share in earnings of joint ventures and associates

Earnings from Aegon’s joint ventures in Spain, China and Japan and Aegon’s associates in India, Brazil and Mexico are reported on an underlying earnings basis.

 

18    Unaudited


Table of Contents

LOGO

 

3.2 Investments geographically

Amounts included in the tables on investments geographically are presented on an IFRS-basis and include the reclassifications following the changes in accounting policies as included in notes 2.1 to 2.4.

 

                                         amounts in million EUR (unless otherwise
stated)
 
Americas
USD
    United
Kingdom
GBP
     September 30, 2013   Americas     The
Netherlands
    United
Kingdom
    New
Markets
    Holding
& other
activities
    Eliminations     Total
EUR
 
         Investments                  
  1,954        43       Shares     1,443        448        52        23        -        (2     1,964   
  79,912        8,837       Debt securities     59,033        19,242        10,571        2,781        -        -        91,627   
  11,730        1       Loans     8,665        23,633        2        513        -        -        32,813   
  11,744        161       Other financial assets     8,676        288        192        23        288        -        9,467   
  984        -       Investments in real estate     727        820        -        1        -        -        1,548   
  106,324        9,042       Investments general account     78,544        44,431        10,817        3,341        288        (2     137,419   
  1,794        13,713       Shares     1,325        7,817        16,405        64        -        (7     25,604   
  6,674        9,904       Debt securities     4,930        17,345        11,848        141        -        -        34,264   
  89,258        20,410       Unconsolidated investment funds     65,936        -        24,418        5,841        -        -        96,195   
  473        2,902       Other financial assets     350        398        3,471        10        -        -        4,229   
  -        730       Investments in real estate     -        -        873        -        -        -        873   
  98,199        47,659       Investments for account of policyholders     72,541        25,560        57,015        6,056        -        (7     161,165   
       
  204,523        56,701       Investments on balance sheet     151,085        69,991        67,832        9,397        288        (9     298,584   
  148,030        190       Off balance sheet investments third parties     109,352        1,010        227        59,800        -        -        170,389   
  352,553        56,891       Total revenue generating investments     260,437        71,001        68,059        69,197        288        (9     468,973   
       
         Investments                  
  87,786        8,998       Available-for-sale     64,849        19,350        10,764        2,797        8        -        97,768   
  11,730        1       Loans     8,665        23,633        2        513        -        -        32,813   
  104,023        46,972       Financial assets at fair value through profit or loss     76,844        26,188        56,193        6,086        280        (9     165,582   
  984        730       Investments in real estate     727        820        873        1        -        -        2,421   
  204,523        56,701       Total investments on balance sheet     151,085        69,991        67,832        9,397        288        (9     298,584   
       
  -        -       Investments in joint ventures     -        817        -        614        -        -        1,431   
  108        16       Investments in associates     80        19        19        342        4        -        464   
  32,893        5,230       Other assets     24,298        19,032        6,256        2,982        32,563        (31,316     53,815   
  237,524        61,947       Consolidated total assets     175,463        89,859        74,107        13,335        32,855        (31,325     354,294   

 

                                         amounts in million EUR (unless otherwise
stated)
 
Americas
USD
    United
Kingdom
GBP
     December 31, 2012   Americas     The
Netherlands
    United
Kingdom
    New
Markets
    Holding
& other
activities
    Eliminations     Total
EUR
 
         Investments                  
  1,833        42       Shares     1,390        412        51        16        -        (2     1,867   
  83,964        8,975       Debt securities     63,686        19,256        11,066        2,817        -        -        96,825   
  11,748        4       Loans     8,910        22,245        5        552        -        -        31,712   
  15,434        175       Other financial assets     11,707        286        216        22        759        -        12,990   
  1,009        -       Investments in real estate     766        860        -        1        -        -        1,627   
  113,988        9,196       Investments general account     86,459        43,059        11,338        3,408        759        (2     145,021   
  1,956        12,107       Shares     1,484        8,406        14,927        63        -        (6     24,874   
  6,988        10,508       Debt securities     5,300        16,266        12,954        162        -        -        34,682   
  77,824        19,136       Unconsolidated investment funds     59,029        -        23,593        5,778        -        -        88,400   
  207        2,761       Other financial assets     157        422        3,404        21        -        -        4,004   
  -        817       Investments in real estate     -        -        1,008        -        -        -        1,008   
  86,975        45,329       Investments for account of policyholders     65,970        25,094        55,886        6,024        -        (6     152,968   
       
  200,963        54,525       Investments on balance sheet     152,429        68,153        67,224        9,432        759        (8     297,989   
  132,796        8       Off balance sheet investments third parties     100,725        1,052        10        59,301        -        -        161,088   
  333,759        54,533       Total revenue generating investments     253,154        69,205        67,234        68,733        759        (8     459,077   
         Investments                  
  95,282        9,155       Available-for-sale     72,271        19,717        11,286        2,826        19        -        106,119   
  11,748        4       Loans     8,910        22,245        5        552        -        -        31,712   
  92,924        44,549       Financial assets at fair value through profit or loss     70,482        25,331        54,925        6,053        740        (8     157,523   
  1,009        817       Investments in real estate     766        860        1,008        1        -        -        2,635   
  200,963        54,525       Total investments on balance sheet     152,429        68,153        67,224        9,432        759        (8     297,989   
       
  -        -       Investments in joint ventures     -        854        -        714        -        -        1,568   
  119        6       Investments in associates     90        21        8        648        4        -        771   
  33,852        5,104       Other assets     25,586        27,508        6,284        3,318        37,926        (36,066     64,556   
  234,934        59,635       Consolidated total assets     178,105        96,536        73,516        14,112        38,689        (36,074     364,884   

4. Premium income and premium to reinsurers

 

                              

EUR millions

    Q3 2013        Q3 2012        YTD 2013        YTD 2012   
     

Gross

           

Life

    3,658        3,625        13,363        12,286   

Non-Life

    675        696        2,184        2,182   

Total

    4,333        4,321        15,547        14,468   
     

Reinsurance

           

Life

    694        826        2,059        2,450   

Non-Life

    85        106        267        307   

Total

    779        932        2,326        2,757   

 

Unaudited    19


Table of Contents

LOGO

 

5. Investment income

 

                              

EUR millions

    Q3 2013        Q3 2012        YTD 2013        YTD 2012   
     

Interest income

    1,712        1,903        5,108        5,614   

Dividend income

    138        331        744        790   

Rental income

    27        30        86        88   

Total investment income

    1,877        2,264        5,938        6,492   
     

Investment income related to general account

    1,398        1,504        4,195        4,453   

Investment income for account of policyholders

    479        760        1,743        2,039   

Total

    1,877        2,264        5,938        6,492   

6. Results from financial transactions

 

                              

EUR millions

    Q3 2013        Q3 2012        YTD 2013        YTD 2012   
     

Net fair value change of general account financial investments at FVTPL other than derivatives

    98        98        221        348   

Realized gains and (losses) on financial investments

    207        137        395        382   

Gains and (losses) on investments in real estate

    (8     (11     (34     (48

Net fair value change of derivatives

    (432     (138     (911     226   

Net fair value change on for account of policyholder financial assets at FVTPL

    4,543        5,116        10,005        9,914   

Net fair value change on investments in real estate for account of policyholders

    (5     (12     (38     (31

Net foreign currency gains and (losses)

    2        2        6        14   

Net fair value change on borrowings and other financial liabilities

    3        (35     36        (41

Realized gains and (losses) on repurchased debt

    -        -        (1     6   

Total

    4,408        5,157        9,679        10,770   

Net fair value change on for accounts of policyholder financial assets at fair value through profit or loss are offset by amounts in the Claims and benefits line reported in note 8 - Benefits and expenses.

7. Other income

Other income of EUR 399 million in 2013 mainly reflects two reinsurance recapture transactions totaling EUR 211 million (Q1 2013: EUR 85 million, Q3 2013: EUR 126 million) and book gains totaling EUR 176 million related to the sale of Unnim and CAM. In the second quarter of 2013, a book gain on Unnim of EUR 102 million included an amount of EUR 26 million which is recycled from equity through profit and loss. In the third quarter of 2013, a net gain of EUR 74 million related to the sale of CAM included a negative amount of EUR 44 million which is recycled from equity through profit and loss.

8. Benefits and expenses

 

                              

EUR millions

    Q3 2013        Q3 2012        YTD 2013        YTD 2012   
     

Claims and benefits

    10,935        12,086        31,712        32,289   

Employee expenses

    502        476        1,542        1,467   

Administration expenses

    304        270        853        782   

Deferred expenses

    (380     (372     (1,147     (1,097

Amortization charges

    288        228        889        898   

Total

    11,649        12,688        33,849        34,339   

Claims and benefits paid to policyholders, includes claims and benefits in excess of account value for products for which deposit accounting is applied and the change in valuation of liabilities for insurance and investment contracts. In addition, commissions and expenses are included, as well as premium paid to reinsurers. Claims and benefits fluctuates mainly as a result of changes in technical provisions resulting from fair value changes on for account of policyholder financial assets included in Results from financial transactions (note 6).

Deferred expenses contain an impairment charge related to Aegon’s Polish pension business. For detailed information refer to note 12, Intangible Assets.

 

20    Unaudited


Table of Contents

LOGO

 

9. Impairment charges/(reversals)

 

                              

EUR millions

    Q3 2013        Q3 2012        YTD 2013        YTD 2012   
     

Impairment charges / (reversals) comprise:

         

Impairment charges on financial assets, excluding receivables 1

    72        55        175        171   

Impairment reversals on financial assets, excluding receivables 1

    (27     (26     (52     (48

Impairment charges / (reversals) on non-financial assets and receivables

    163        3        159        7   

Total

    208        32        282        130   
     

Impairment charges on financial assets, excluding receivables, from:

         

Shares

    -        1        -        5   

Debt securities and money market instruments

    53        43        116        129   

Loans

    18        11        58        36   

Other

    -        -        -        1   

Investments in associates

    1        -        1        -   

Total

    72        55        175        171   
     

Impairment reversals on financial assets, excluding receivables, from:

         

Debt securities and money market instruments

    (26     (17     (48     (34

Loans

    (1     (9     (4     (14

Total

    (27     (26     (52     (48

1 Impairment charges / (reversals) on financial assets, excluding receivables, are excluded from underlying earnings before tax for segment reporting (refer to note 3).

Impairment charges on non-financial assets and receivables contain an impairment charge related to Aegon’s Polish pension business. For detailed information refer to note 12, Intangible Assets.

10. Other charges

Other charges of EUR 135 million in 2013 mainly included EUR 81 million related to a further increase in reserves in connection with the company’s use of the Social Security Administration’s death master-file in the United States. Additionally, it includes a loss of EUR 22 million related to the sale of national independent financial advisor Positive Solutions in the United Kingdom.

Other charges of EUR 19 million in 2012 mainly includes EUR 16 million related to the Hungarian bank tax. Due to regulation changes in Hungary, the bank tax has been replaced by a recurring insurance tax for which charges are recognized in operating expenses effective January 1, 2013.

11. Income tax

In the third quarter of 2013 there is a beneficial impact on the deferred tax position as a result of the decreasing corporate income tax rate in the United Kingdom. The corporate income tax rate in the United Kingdom will decrease from 23% in 2013 to 21% as from April 1, 2014 and to 20% as from April 1, 2015.

12. Intangible assets

 

                

EUR millions

    Sept. 30, 2013        Dec. 31, 2012   
   

Goodwill

    212        266   

VOBA

    1,763        1,777   

Future servicing rights

    259        383   

Software

    52        50   

Other

    4        9   

Total intangible assets

    2,290        2,485   

The Polish government released its pension reform proposal that is expected to be enacted into legislation. The outcome adversely impacts Aegon’s Polish pension business growth and profitability from current in-force business. As a result, Aegon impaired intangibles related to this business: goodwill (EUR 53 million); future servicing rights (EUR 102 million); and DPAC write offs (EUR 27 million). The DPAC write offs are included in the deferred expenses and rebates (note 17).

 

Unaudited    21


Table of Contents

LOGO

 

13. Investments

 

                              

EUR millions

    Sept. 30, 2013        Dec. 31, 2012   
   

Available-for-sale (AFS)

    97,768        106,119   

Loans

    32,813        31,712   

Financial assets at fair value through profit or loss (FVTPL)

    5,290        5,563   

Financial assets, excluding derivatives

    135,871        143,394   

Investments in real estate

    1,548        1,627   

Total investments for general account

    137,419        145,021   
   

Total financial assets, excluding derivatives

         
      AFS        FVTPL        Loans        Total   
   

Shares

    789        1,175        -        1,964   

Debt securities

    90,016        1,611        -        91,627   

Money market and other short-term investments

    5,791        638        -        6,429   

Mortgages

    -        -        29,518        29,518   

Private loans

    -        -        1,047        1,047   

Deposits with financial institutions

    -        -        92        92   

Policy loans

    -        -        2,018        2,018   

Other

    1,172        1,866        138        3,176   

September 30, 2013

    97,768        5,290        32,813        135,871   
   
      AFS        FVTPL        Loans        Total   
   

Shares

    824        1,043        -        1,867   

Debt securities

    95,394        1,431        -        96,825   

Money market and other short-term investments

    8,687        1,084        -        9,771   

Mortgages

    -        -        28,350        28,350   

Private loans

    -        -        1,012        1,012   

Deposits with financial institutions

    -        -        96        96   

Policy loans

    -        -        2,103        2,103   

Other

    1,214        2,005        151        3,370   

December 31, 2012

    106,119        5,563        31,712        143,394   

European peripheral countries exposure

The following table provides the amortized cost and fair value of Aegon’s exposure to European peripheral countries. Investments held by joint ventures and associates are not included.

 

                                                                 

EUR millions

Debt security exposure to:

    Sept. 30, 2013  
     Central Government     Banks     RMBS     Corporates and other     Total  
             
     Amortized
cost
    Fair value     Amortized
cost
    Fair value     Amortized
cost
    Fair value     Amortized
cost
    Fair value     Amortized
cost
    Fair value  
             

Portugal

    1        1        -        -        28        25        46        45        75        71   

Italy

    77        77        95        96        29        28        534        520        735        721   

Ireland

    3        3        -        -        61        53        409        424        473        480   

Greece

    -        -        -        -        3        3        1        1        4        4   

Spain

    308        324        126        116        198        194        555        577        1,187        1,211   

Total

    389        405        221        212        319        303        1,545        1,567        2,474        2,487   
                   
                                                                 

EUR millions

Debt security exposure to:

    Dec. 31, 2012  
     Central Government     Banks     RMBS     Corporates and other     Total  
             
     Amortized
cost
    Fair value     Amortized
cost
    Fair value     Amortized
cost
    Fair value     Amortized
cost
    Fair value     Amortized
cost
    Fair value  
             

Portugal

    1        1        -        -        31        27        47        45        79        73   

Italy

    36        36        78        76        33        33        563        562        710        707   

Ireland

    18        18        -        -        160        140        295        324        473        482   

Greece

    -        -        -        -        4        2        23        25        27        27   

Spain

    275        268        118        107        183        171        574        601        1,150        1,147   

Total

    330        323        196        183        411        373        1,502        1,557        2,439        2,436   

 

22    Unaudited


Table of Contents

LOGO

 

14. Investments for account of policyholders

 

                
EUR millions   Sept. 30, 2013     Dec. 31, 2012  

Shares

    25,604        24,874   

Debt securities

    34,264        34,682   

Money market and short-term investments

    924        1,480   

Deposits with financial institutions

    2,896        2,087   

Unconsolidated investment funds

    96,195        88,400   

Other

    409        437   

Total investments for account of policyholders at fair value through profit or loss, excluding derivatives

    160,292        151,960   

Investment in real estate

    873        1,008   

Total investments for account of policyholders

    161,165        152,968   

15. Derivatives

The movements in derivative balances mainly result from changes in interest rates and other market conditions.

16. Fair value

The table below provides an analysis of financial instruments recorded at fair value on a recurring basis by level of the fair value hierarchy:

 

Fair value hierarchy                              
         
EUR millions   Level I     Level II     Level III     Total  

Financial assets carried at fair value

           

Available-for-sale investments

           

Shares

    202        258        329        789   

Debt securities

    21,182        66,089        2,745        90,016   

Money markets and other short-term instruments

    -        5,791        -        5,791   

Other investments at fair value

    24        307        841        1,172   

September 30, 2013

    21,408        72,445        3,915        97,768   
     

Fair value through profit or loss

           

Shares

    1,077        98        -        1,175   

Debt securities

    109        1,491        11        1,611   

Money markets and other short-term instruments

    280        358        -        638   

Other investments at fair value

    -        522        1,344        1,866   

Investments for account of policyholders 1

    96,234        62,198        1,860        160,292   

Derivatives

    23        14,201        231        14,455   

September 30, 2013

    97,723        78,868        3,446        180,037   

Total financial assets at fair value

    119,131        151,313        7,361        277,805   
     

Financial liabilities carried at fair value

           

Investment contracts for account of policyholders 2

    12,053        20,616        117        32,786   

Borrowings 3

    521        484        -        1,005   

Derivatives

    55        10,956        1,611        12,622   

Total financial liabilities at fair value

    12,629        32,056        1,728        46,413   

1 The investments for account of policyholders included in the table above represents those investments carried at fair value through profit or loss.

2 The investment contracts for account of policyholders included in the table above represents those investment contracts carried at fair value.

3 Total borrowings on the statement of financial position contain borrowings carried at amortized cost that are not included in the above schedule.

 

Unaudited    23


Table of Contents

LOGO

 

Significant transfers between Level I and II

Aegon’s policy is to record transfers of assets and liabilities between Level I and Level II at their fair values as of the beginning of each reporting period. During the first nine months of 2013, the amount of assets and liabilities transferred from Level II to Level I was EUR 467 million. Transfers are identified based on transaction volume and frequency, which are indicative of an active market.

The table below shows transfers between Level I and II for financial assets and financial liabilities recorded at fair value on a recurring basis during the nine-month period ended September 30, 2013:

 

Fair value transfers                
EUR millions   Transfers
Level I to
Level II
    Transfers
Level II to
Level I
 

Financial assets carried at fair value available-for-sale investments

     

Shares

    -        1   

Debt securities

    2        237   

September 30, 2013

    2        238   
   

Fair value through profit or loss

     

Investments for account of policyholders

    -        229   

September 30, 2013

    -        229   

Total financial assets at fair value

    2        467   

Movements in Level III financial instruments measured at fair value

The following table summarizes the change of all assets and liabilities measured at estimated fair value on a recurring basis using significant unobservable inputs (Level III), including realized and unrealized gains (losses) of all assets and liabilities and unrealized gains (losses) of all assets and liabilities still held at the end of the respective period.

 

Roll forward of Level III financial instruments                                              
     January 1,
2013
    Total gains /
losses in
income
statement 1
    Total gains /
losses in OCI 2
    Purchases     Sales     Settlements     Net exchange
differences
    Transfers from
Level I and
Level II
    Transfers to
Level I and
Level II
    September 30,
2013
   

Total unrealized gains
and losses for the

period recorded in

the P&L for
instruments held at
September 30, 2013 3

 

Financial assets carried at fair value available-for-sale investments

                         

Shares

    376        4        9        19        (69     (5     (4     -        (1     329        -   

Debt securities

    2,643        11        103        845        (173     (395     (52     246        (483     2,745        -   

Other investments at fair value

    883        (90     78        86        (25     (69     (22     -        -        841        -   
      3,902        (75     190        950        (267     (469     (78     246        (484     3,915        -   
     

Fair value through profit or loss

                         

Debt securities

    14        (2     -        -        -        (1     -        2        (2     11        1   

Other investments at fair value

    1,416        94        -        24        (216     -        (36     106        (44     1,344        98   

Investments for account of policyholders

    1,715        131        -        170        (222     -        (12     122        (44     1,860        64   

Derivatives

    301        (54     -        3        (14     -        (5     -        -        231        (23
      3,446        169        -        197        (452     (1     (53     230        (90     3,446        140   
     

Financial liabilities carried at fair value

                         

Investment contracts for account of policyholders

    (109     (18     -        (3     10        -        3        -        -        (117     (17

Derivatives

    (2,318     698        -        -        -        -        7        -        2        (1,611     680   
      (2,427     680        -        (3     10        -        10        -        2        (1,728     663   

1 Includes impairments and movements related to fair value hedges. Gains and losses are recorded in the line item results from financial transactions of the income statement.

2 Total gains and losses are recorded in line items Gains / (losses) on revaluation of available-for-sale investments and (Gains) / losses transferred to the income statement on disposal and impairment of available-for-sale investment of the statement of other comprehensive income.

3 Total gains / (losses) for the period during which the financial instrument was in Level III.

Aegon’s policy is to record transfers of assets and liabilities between Level I, Level II and Level III at their fair values as of the beginning of each reporting period. During the third quarter of 2013, Aegon transferred certain financial instruments from Level I and Level II to Level III of the fair value hierarchy. The reason for the change in level was that the market liquidity for these securities decreased, which led to a change in market observability of prices. Prior to transfer, the fair value for the Level I and Level II securities was determined using observable market transactions or corroborated broker quotes respectively for the same or similar instruments. Since the transfer, all such assets have been valued using valuation models incorporating significant non market-observable inputs or uncorroborated broker quotes.

 

24    Unaudited


Table of Contents

LOGO

 

Similarly, during the third quarter of 2013, Aegon transferred certain financial instruments from Level III to other levels of the fair value hierarchy. The change in level was mainly the result of a return of activity in the market for these securities and that for these securities the fair value could be determined using observable market transactions or corroborated broker quotes for the same or similar instruments.

The table below presents information about the significant unobservable inputs used for recurring fair value measurements for certain Level III financial instruments.

 

Overview of significant unobservable inputs            
EUR millions   Carrying
amount September 30,
2013
        Valuation technique 1       Significant unobservable
input 2
      Range (weighted  average)

Financial assets carried at fair value available-for-sale investments

         

Shares

    204      Broker quote   n.a.   n.a.
      125      Other   n.a.   n.a.
      329               
   

Debt securities

         

RMBS

    204      Broker quote   n.a.   n.a.
      62      Other   n.a.   n.a.

CMBS

    38      Broker quote   n.a.   n.a.
      3      Other   n.a.   n.a.

ABS

    217      Discounted cash flow   Discount rate   3% - 8% (6.69%)
      1,606      Broker quote   n.a.   n.a.
      88      Other   n.a.   n.a.

Corporate bonds

    216      Discounted cash flow   Credit spread   0.1% - 3.1% (2.46%)
      271      Broker quote   n.a.   n.a.
      20      Other   n.a.   n.a.

Sovereign debt

    20      Broker quote   n.a.   n.a.
      2,745               
   

Other investments at fair value

         

Tax credit investments

    703      Discounted cash flow   Discount rate   8.2%

Other

    135      Net asset value   n.a.   n.a.
      3      Other   n.a.   n.a.
      841               

September 30, 2013

    3,915               
   

Fair value through profit or loss

         

Debt securities

    11      Other   n.a.   n.a.
   

Other investments at fair value

         

Real estate investments

    674      Net asset value   n.a.   n.a.

Private equity investments

    583      Net asset value   n.a.   n.a.

Hedge funds

    87      Net asset value   n.a.   n.a.
      1,344               
   

Derivatives

    136      Discounted cash flow   Mortality   n.a.
      136               

September 30, 2013

    1,491               
   

Total financial assets at fair value

    5,406               
   

Financial liabilities carried at fair value

         

Derivatives

         

Embedded derivatives in insurance contracts

    1,425      Discounted cash flow   Credit spread   0.55%

Other

    186      Other   n.a.   n.a.

Total financial liabilities at fair value

    1,611               

1 Other in the table above (column Valuation technique) includes investments for which the fair value is uncorroborated and no broker quote is received.

2 Not applicable (n.a.) has been included when no significant unobservable assumption has been identified and used.

Investments for account of policyholders are excluded from the table above and from the disclosure regarding reasonably possible alternative assumptions. Policyholder assets, and their returns, belong to policyholders and do not impact Aegon’s net income or equity. The effect on total assets is offset by the effect on total liabilities. Derivatives exclude derivatives for account of policyholders amounting to EUR 81 million.

 

Unaudited    25


Table of Contents

LOGO

 

The valuation techniques included in the table above are described in more detail below:

Shares

When available, Aegon uses quoted market prices in active markets to determine the fair value of its investments in shares. Fair values for unquoted shares are estimated using observations of the price/earnings or price/cash flow ratios of quoted companies considered comparable to the companies being valued. Valuations are adjusted to account for company-specific issues and the lack of liquidity inherent in an unquoted investment. Illiquidity adjustments are generally based on available market evidence. In addition, a variety of other factors are reviewed by management, including, but not limited to, current operating performance, changes in market outlook and the third-party financing environment.

Available-for-sale shares include shares in the Federal Home Loan Bank for an amount of EUR 96 million that are measured at par, which are reported as part of Other. The bank has implicit financial support from the United States government. The redemption value of the shares is fixed at par and they can only be redeemed by the bank.

Residential mortgage-backed securities (RMBS), commercial mortgage-backed securities (CMBS) and asset-backed securities (ABS)

Valuations of RMBS, CMBS and ABS are monitored and reviewed on a monthly basis. Valuations are based on a pricing hierarchy and depending on the asset type, the pricing hierarchy consists of a waterfall that starts with making use of market prices from indices and follows with making use of third-party pricing services or brokers. The pricing hierarchy is dependent on the possibilities of corroboration of the market prices. If no market prices are available, Aegon uses internal models to determine fair value. Significant inputs included in the internal models are generally determined based on relative value analyses, which incorporate comparisons to instruments with similar collateral and risk profiles. Market standard models may be used to model the specific collateral composition and cash flow structure of each transaction. The most significant unobservable input is illiquidity premium which is embedded in the discount rate.

Corporate bonds

Valuations of corporate bonds are monitored and reviewed on a monthly basis. The pricing hierarchy is dependent on the possibility of corroboration of market prices when available. If no market prices are available, valuations are determined by a discounted cash flow methodology using an internally calculated yield. The yield is comprised of a credit spread over a given benchmark. In all cases, the benchmark is an observable input. The credit spread contains both observable and unobservable inputs. Aegon starts by taking an observable credit spread from a similar bond of the given issuer, and then adjust this spread based on unobservable inputs. These unobservable inputs may include subordination, liquidity and maturity differences.

Tax credit investments

The fair value of tax credit investments is determined by using a discounted cash flow valuation technique. This valuation technique takes into consideration projections of future capital contributions and distributions, as well as future tax credits and the tax benefits of future operating losses. The present value of these cash flows is calculated by applying a discount rate. In general, the discount rate is determined based on the cash outflows for the investments and the cash inflows from the tax credits/tax benefits (and the timing of those cash flows). These inputs are unobservable in the market place.

Real estate investments, private equity investments and hedge funds

The fair values of investments held in non-quoted investment funds are determined by management after taking into consideration information provided by the fund managers. Aegon reviews the valuations each month and performs analytical procedures and trending analyses to ensure the fair values are appropriate.

 

26    Unaudited


Table of Contents

LOGO

 

Sovereign debt

When available, Aegon uses quoted market prices in active markets to determine the fair value of its sovereign debt investments. When Aegon cannot make use of quoted market prices, market prices from indices or quotes from third-party pricing services or brokers are used.

Derivatives

Where quoted market prices are not available, other valuation techniques, such as option pricing or stochastic modeling, are applied. The valuation techniques incorporate all factors that a typical market participant would consider and are based on observable market data when available. Models are validated before they are used and calibrated to ensure that outputs reflect actual experience and comparable market prices.

Fair values for exchange-traded derivatives, principally futures and certain options, are based on quoted market prices in active markets. Fair values for over-the-counter (OTC) derivatives represent amounts estimated to be received from or paid to a third party in settlement of these instruments. These derivatives are valued using pricing models based on the net present value of estimated future cash flows, directly observed prices from exchange-traded derivatives, other OTC trades, or external pricing services. Most valuations are derived from swap and volatility matrices, which are constructed for applicable indices and currencies using current market data from many industry standard sources. Option pricing is based on industry standard valuation models and current market levels, where applicable. The pricing of complex or illiquid instruments is based on internal models or an independent third party. For long-dated illiquid contracts, extrapolation methods are applied to observed market data in order to estimate inputs and assumptions that are not directly observable. To value OTC derivatives, management uses observed market information, other trades in the market and dealer prices.

Derivatives at fair value through profit or loss consist of a longevity derivative. The payout of the longevity derivative is linked to an annually publicly available mortality table. The derivative is measured using the present value of the best estimate of expected payouts of the derivative plus a risk margin. The best estimate of expected payouts is determined using best estimate of mortality developments. Aegon determined the risk margin by stressing the best estimate mortality developments to quantify the risk and applying a cost-of-capital methodology. The most significant unobservable input for these derivatives is the (projected) mortality development.

Aegon normally mitigates counterparty credit risk in derivative contracts by entering into collateral agreements where practical and in ISDA master netting agreements for each of the Group’s legal entities to facilitate Aegon’s right to offset credit risk exposure. Changes in the fair value of derivatives attributable to changes in counterparty credit risk were not significant.

Embedded derivatives in insurance contracts including guarantees

Certain bifurcated guarantees for minimum benefits in insurance and investment contracts are carried at fair value. These guarantees include guaranteed minimum withdrawal benefits (GMWB) in the United States, United Kingdom and Japan which are offered on some variable annuity products and are also assumed from a ceding company; minimum interest rate guarantees on insurance products offered in the Netherlands, including group pension and traditional products; and guaranteed minimum accumulation benefits on segregated funds sold in Canada.

Since the price of these guarantees is not quoted in any market, the fair values of these guarantees are calculated as the present value of future expected payments to policyholders less the present value of assessed rider fees attributable to the guarantees. Given the complexity and long-term nature of these guarantees which are unlike instruments available in financial markets, their fair values are determined by using stochastic techniques under a variety of market return scenarios. A variety of factors are considered including credit spread, expected market rates of return, equity and interest rate volatility, correlations of market returns, discount rates and actuarial assumptions. The most significant unobservable factor is credit spread.

 

Unaudited    27


Table of Contents

LOGO

 

The expected returns are based on risk-free rates. Aegon added a premium to reflect the credit spread as required. The credit spread is set by using the credit default swap (CDS) spreads of a reference portfolio of life insurance companies (including Aegon), adjusted to reflect the subordination of senior debt holders at the holding company level to the position of policyholders at the operating company level (who have priority in payments to other creditors). Aegon’s assumptions are set by region to reflect differences in the valuation of the guarantee embedded in the insurance contracts.

Assumptions are reviewed at each valuation date, and updated based on historical experience and observable market data, including market transactions such as acquisitions and reinsurance transactions. Assumptions regarding policyholder behavior, such as lapses, included in the models are derived in the same way as the assumptions used to measure insurance liabilities.

In the third quarter of 2013, Aegon updated the way it extrapolates yield curves beyond market observable maturities. The discount rates converge lineary in 10 years to an Ultimate Forward Rate of 4.25% from the last liquid point at 30 years. The uniform last liquid point for all Aegon’s major currencies (USD, GBP and EUR) is set at 30 years. Additionally, Aegon updated the manner in which it estimates guarantees embedded within individual life contracts in The Netherlands. The impact of these updates was EUR 27 million negative.

 

Effect of reasonably possible alternative assumptions

 

               
EUR millions   Carrying
amount September 30,
2013
    Significant unobservable
input
   Note     Effect of reasonably possible
alternative assumptions (+/-)
 
                           increase        decrease   

Financial assets carried at fair value available-for-sale investments

            

Debt securities

            

ABS

    217      Discount rate      a        21        (16

Corporate bonds

    216      Credit spread      b        24        (18
   

Other investments at fair value

            

Tax credit investments

    703      Discount rate      c        14        (13
   

Fair value through profit or loss

            

Derivatives

    136      Mortality      d        12        (12
   

Financial liabilities carried at fair value

            

Embedded derivatives in insurance contracts

    1,425      Credit spread      e        87        (84

The table above presents the impact on a fair value measurement of a change in an unobservable input. The impact of changes in inputs may not be independent, therefore the descriptions provided below indicate the impact of a change in an input in isolation.

 

a) The primary unobservable assumptions used in fair value measurement of asset backed securities is in general a liquidity premium in the discount rate. Changing the liquidity premium changes the discount rate when using the discounted cash flow model. Increasing or decreasing the liquidity premium respectively decreases or increases the value of the investment. Aegon adjusted the discount rate with 100 basis points up or down for this input.

 

b) For corporate bonds, the most significant unobservable input for the valuation of these securities is the credit spread. An increase in credit spread results in a lower valuation, while a decrease in credit spread results in a higher valuation. Aegon adjusted the discount rate by 50 basis points up or down for this input.

 

c) Tax credit investments are measured at fair value using an internal model. The most significant unobservable input for valuation of these tax credits is the discount rate. Increasing or decreasing the discount rate would result in respectively a lower or higher valuation. Aegon adjusted the discount rate by 50 basis points up or down for this input.

 

d) The derivative included is a longevity Index derivative. Most significant unobservable input is expected mortality. Changing the expected mortality changes the cash flow expectations from this derivative. Increasing (decreasing) the mortality rates decreases (increases) the value of the investment. Aegon adjusted longevity with 2% up or down for this input, compared to the expected mortality in determining the value of this derivative.

 

28    Unaudited


Table of Contents

LOGO

 

e) To determine the fair value of the bifurcated embedded derivatives related to guarantees, a discount rate is used including credit spread. An increase in the credit spread results in lower valuation, while a decrease results in a higher valuation of the embedded derivatives. Aegon increased or decreased the credit spread by 20 basis points.

 

Fair value information about financial instruments not measured at fair value

 

 
EUR millions   Carrying
amount September 30,
2013
   

Total

estimated fair
value September 30,
2013

 
   

Assets

     

Mortgage loans - held at amortized cost

    29,518        33,972   

Private loans - held at amortized cost

    1,047        1,127   

Other loans - held at amortized cost

    2,248        2,248   
   

Liabilities

     

Trust pass-through securities - held at amortized cost

    140        125   

Subordinated borrowings - held at amortized cost

    44        62   

Borrowings – held at amortized cost

    11,167        11,466   

The following table presents the carrying values and estimated fair values of financial assets and liabilities, excluding financial instruments which are carried at fair value on a recurring basis.

Financial instruments for which carrying value approximates fair value

Certain financial instruments that are not carried at fair value are carried at amounts that approximate fair value, due to their short-term nature and generally negligible credit risk. These instruments include cash and cash equivalents, short-term receivables and accrued interest receivable, short-term liabilities, and accrued liabilities. These instruments are not included in the table above.

17. Deferred expenses and rebates

 

                

EUR millions

    Sept. 30, 2013        Dec. 31, 2012   
     

DPAC for insurance contracts and investment contracts with discretionary participation features

    11,162        10,681   

Deferred cost of reinsurance

    514        558   

Deferred transaction costs for investment management services

    362        405   

Total deferred expenses and rebates

    12,038        11,644   

 

                

EUR millions

    Sept. 30, 2013        Dec. 31, 2012   
     

Share capital - par value

    326        319   

Share premium

    8,375        8,780   

Total share capital

    8,701        9,099   
     

Share capital - par value

       

Balance at January 1

    319        310   

Issuance

    84        2   

Withdrawal

    (82     -   

Share dividend

    5        7   

Balance

    326        319   
     

Share premium

       

Balance at January 1

    8,780        8,787   

Withdrawal

    (400     -   

Share dividend

    (5     (7

Balance

    8,375        8,780   

 

Unaudited    29


Table of Contents

LOGO

 

18. Share capital

On February 15, 2013, Aegon and Vereniging Aegon (‘the Association’) announced their agreement to cancel all of Aegon’s preferred shares, of which the Association was the sole owner. Following the approval of the new capital structure by the Annual General Meeting of Shareholders on May 15, 2013, Aegon has exchanged all preferred shares for EUR 400 million in cash, the equivalent of EUR 655 million in common shares and EUR 83 million of dividends on the preferred shares.

Based on the volume-weighted average price of Aegon common shares on Euronext Amsterdam of EUR 4.86, which was announced on March 1, 2013, the preferred shares were converted into 121 million common shares and 566 million common shares B. Following the conversion, the Association obtained a total of 293 million common shares and 566 million common shares B.

In addition, in Q2 2013, Vereniging Aegon exercised its option right to purchase 13 million common shares B for EUR 0.1275 to correct the dilution caused by the issuance of shares bringing the total of common shares B held by Vereniging Aegon at 579 million.

 

           
                              

EUR millions

    Q3 2013        Q3 2012        YTD 2013        YTD 2012   
     

Earnings per share (EUR per share)

           

Basic earnings per common share

    0.08        0.17        0.23        0.50   

Basic earnings per common share B

    -        -        0.01        -   

Diluted earnings per common share

    0.08        0.17        0.23        0.50   

Diluted earnings per common share B

    -        -        0.01        -   

Earnings per share calculation

           

Net income attributable to equity holders of Aegon N.V.

    227        376        673        1,150   

Preferred dividend

    -        -        (83     (59

Coupons on other equity instruments

    (51     (48     (120     (146

Earnings attributable to common shares and common shares B

    176        328        470        945   
     

Earnings attributable to common shareholders

    176        328        469        945   

Earnings attributable to common shareholders B

    -        -        1        -   
     

Weighted average number of common shares outstanding (in million)

    2,098        1,919        2,017        1,895   

Weighted average number of common shares B outstanding (in million)

    14        -        7        -   

Basic and diluted earnings per share

Diluted earnings per share is calculated by adjusting the average number of shares outstanding for share options. During the first nine months ending September 30, 2013, and during 2012, the average share price did not exceed the exercise price of these options. As a result, diluted earnings per share do not differ from basic earnings per share.

Interim dividend

The interim dividend 2013 was paid in cash or stock at the election of the shareholder. Stock dividend amounts to one new Aegon common share for every 50 common shares held. The stock dividend and cash dividend are approximately equal in value. The interim dividend was payable as of September 13, 2013. The interim dividend 2013 for common shares B is EUR 0.0028, fully paid in cash.

The Annual General Meeting of Shareholders on May 15, 2013, approved a final dividend over 2012 payable in either cash or stock related to the second half of 2012, paid in the first half of 2013. The cash dividend amounted to EUR 0.11 per common share, and the stock dividend amounted to one new Aegon common share for every 47 common shares held. The stock dividend and cash dividend are approximately equal in value. No dividends were paid on common shares B.

 

30    Unaudited


Table of Contents

LOGO

 

Approximately 55% of shareholders have elected to receive the cash dividend. The remaining 45% have opted for stock dividend. Aegon repurchased since the program is complete common shares to neutralize the dilutive effect of the 2013 interim dividend paid in shares. Between September 17, 2013, and October 14, 2013, 19,047,358 common shares were repurchased under the share buyback program, at an average price of EUR 5.6233 per share.

19. Borrowings

 

    
EUR millions   Sept. 30, 2013     Dec. 31, 2012  
     

Debentures and other loans

    11,901        13,219   

Commercial paper

    145        413   

Short-term deposits

    16        17   

Bank overdrafts

    109        93   

Total borrowings

    12,171        13,742   

Debentures and other loans

Included in Debentures and other loans is EUR 1,005 million relating to borrowings measured at fair value (2012: EUR 1,050 million).

On March 26, 2013, Aegon signed an agreement with a third party to sell class A mortgage backed securities (RMBS) amounting to EUR 750 million. These securities consist of two tranches:

 

t  

EUR 100 million of class A1 notes with an expected weighted average life of two years and priced with a coupon of three month Euribor plus 0.40%; and

t  

EUR 650 million of class A2 notes with an expected weighted average life of five years and priced with a coupon of three month Euribor plus 0.82%.

On June 3, 2013, Aegon redeemed USD 750 million senior notes (EUR 580 million), which matured.

In August, 2013, Aegon repaid EUR 1,168 million Saecure 6 Mortgage Backed Notes using the first optional redemption date.

Commercial paper, Short-term deposits and Bank overdrafts vary with the normal course of business.

20. Offsetting, enforceable master netting arrangements and similar agreements

The following table provides details relating to the effect or potential effect of netting arrangements, including rights of set-off associated with the entity’s recognized financial assets and recognized financial liabilities.

 

Unaudited    31


Table of Contents

LOGO

 

 
Financial assets subject to offsetting, enforceable master netting arrangements and similar agreements  
                          Related amounts not set off in the statements
of financial position
        
EUR millions   Gross amounts of
recognized financial
assets
    Gross amounts of
recognized financial
liabilities set off in  the
statement of financial
position
    Net amounts of
financial assets
presented in the
statement of  financial
position
    Financial instruments    

Cash collateral received
(excluding surplus

collateral)

    Net amount  

Derivatives

    14,343        32        14,311        10,500        3,285        526   

September 30, 2013

    14,343        32        14,311        10,500        3,285        526   

    

                                               
 
Financial liabilities subject to offsetting, enforceable master netting arrangements and similar agreements  
                          Related amounts not set off in the statements
of financial position
        
EUR millions   Gross amounts of
recognized financial
liabilities
    Gross amounts of
recognized financial
assets set off in the
statement of financial
position
    Net amounts of
financial liabilities
presented in the
statement of financial
position
    Financial instruments     Cash collateral pleged
(excluding surplus
collateral)
    Net amount  

Derivatives

    10,991        32        10,959        10,512        127        320   

September 30, 2013

    10,991        32        10,959        10,512        127        320   
           
 
Financial assets subject to offsetting, enforceable master netting arrangements and similar agreements  
                          Related amounts not set off in the statements
of financial position
        
EUR millions   Gross amounts of
recognized financial
assets
    Gross amounts of
recognized financial
liabilities set off in the
statement of financial
position
    Net amounts of
financial assets
presented in the
statement of financial
position
    Financial instruments     Cash collateral received
(excluding surplus
collateral)
    Net amount  

Derivatives

    20,776        40        20,736        15,584        4,686        466   

December 31, 2012

    20,776        40        20,736        15,584        4,686        466   

    

                                               
 
Financial liabilities subject to offsetting, enforceable master netting arrangements and similar agreements  
                          Related amounts not set off in the statements
of financial position
        
EUR millions   Gross amounts of
recognized financial
liabilities
    Gross amounts of
recognized financial
assets set off in the
statement of financial
position
    Net amounts of
financial liabilities
presented in the
statement of financial
position
    Financial instruments     Cash collateral pleged
(excluding surplus
collateral)
    Net amount  

Derivatives

    15,471        40        15,431        15,099        2        329   

December 31, 2012

    15,471        40        15,431        15,099        2        329   

Financial assets and liabilities are offset in the statement of financial position when the Group has a legally enforceable right to offset and has the intention to settle the asset and liability on a net basis, or to realize the asset and settle the liability simultaneously.

Aegon mitigates credit risk in derivative contracts by entering into collateral agreements, where practical, and in ISDA master netting agreements for each of the Aegon’s legal entities to facilitate Aegon’s right to offset credit risk exposure. The credit support agreement will normally dictate the threshold over which collateral needs to be pledged by Aegon or its counterparty. Transactions requiring Aegon or its counterparty to post collateral are typically the result of over-the-counter derivative trades, comprised mostly of interest rate swaps, currency swaps and credit swaps. These transactions are conducted under terms that are usual and customary to standard long-term borrowing, derivative, securities lending and securities borrowing activities, as well as requirements determined by exchanges where the bank acts as intermediary.

 

32    Unaudited


Table of Contents

LOGO

 

21. Commitments and contingencies

KoersPlan

On June 14, 2013, the Supreme Court denied Aegon’s appeal and confirmed the ruling of the Court of Appeal from 2011 in the KoersPlan case. Aegon will compensate the approximately 35.000 policyholders of KoersPlan-products who were plaintiffs in the litigation. The provisions recorded are sufficient to cover the compensation for these plaintiffs.

There have been no other material changes in contingent assets and liabilities as reported in the 2012 consolidated financial statements of Aegon.

22. Acquisitions/Divestments

Fidem Life

On February 8, 2013, Aegon closed the acquisition of 100% of Fidem Life, a life insurance company in Ukraine. Fidem Life is rebranded ‘Aegon Ukraine’ and is integrated into the governance and management structure of Aegon CEE.

Strategic partnership with Banco Santander

On June 3, 2013, Aegon has completed an exclusive 25-year strategic partnership with Banco Santander, Spain’s largest financial group, first announced last December. Under the terms of the agreement, Aegon has acquired a 51% stake in both a life insurance company as well as in a non-life insurance company for a consideration of EUR 220 million. The joint ventures will distribute life and general insurance products through Banco Santander’s extensive branch network. Aegon Spain will provide the back-office services to the joint venture companies.

Unnim

On May 7, 2013, Aegon has finalized exiting its life, health and pension joint venture with Unnim and sold its 50% stake to Unnim for a total consideration of EUR 353 million. The sale resulted in a book gain of EUR 102 million before tax.

Positive Solutions

On June 12, 2013, Aegon UK announced the sale of national independent financial advisor (IFA) Positive Solutions to Intrinsic Financial Services. The loss on the sale amounts to EUR 22 mln. The sale is completed in the third quarter.

CAM

On July 19, 2013, the sale of Aegon’s 50% stake in its life insurance partnership originally established with Caja de Ahorros del Mediterráneo (CAM), recorded as an associate, was closed. The consideration amounted to EUR 449.5 million and resulted in a book gain of EUR 74 million.

Czech pension company

Aegon Czech Republic has announced the sale of its local pension business. The transaction is pending regulatory approval. The loss on the sale amounts to EUR 6 million. The sale is expected to complete in the fourth quarter of 2013 or the first quarter of 2014.

23. Events after the balance sheet date

There were no events after the balance sheet date with a significant impact on the financial position of the company per September 30, 2013.

 

Unaudited    33


Table of Contents

LOGO

 

Disclaimers

Cautionary note regarding non-IFRS measures

This document includes the non-IFRS financial measures: underlying earnings before tax, income tax and income before tax. These non-IFRS measures are calculated by consolidating on a proportionate basis Aegon’s joint ventures and associated companies. The reconciliation of these measures to the most comparable IFRS measures is provided in note 3 ‘Segment information’of Aegon’s Condensed Consolidated Interim Financial Statements. Aegon believes that its non-IFRS measures, together with the IFRS information, provide meaningful information about the underlying operating results of Aegon’s business including insight into the financial measures that senior management uses in managing the business.

Local currencies and constant currency exchange rates

This document contains certain information about Aegon’s results and financial condition presented in USD for the Americas and GBP for the United Kingdom, because those businesses operate and are managed primarily in those currencies. None of this information is a substitute for or superior to financial information about Aegon presented in EUR, which is the currency of Aegon’s primary financial statements.

Forward-looking statements

The statements contained in this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to Aegon. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:

 

t  

Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom.

t  

Changes in the performance of financial markets, including emerging markets, such as with regard to:

  The frequency and severity of defaults by issuers in Aegon’s fixed income investment portfolios;
  The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities Aegon holds; and
  The effects of declining creditworthiness of certain private sector securities and the resulting decline in the value of sovereign exposure that Aegon holds.
t  

Changes in the performance of Aegon’s investment portfolio and decline in ratings of Aegon’s counterparties.

t  

Consequences of a potential (partial) break-up of the euro.

t  

The frequency and severity of insured loss events.

t  

Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the profitability of Aegon’s insurance products.

t  

Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations.

t  

Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels.

t  

Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates.

t  

Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness.

t  

Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets.

t  

Changes in laws and regulations, particularly those affecting Aegon’s operations, ability to hire and retain key personnel, the products Aegon sells, and the attractiveness of certain products to its consumers.

t  

Regulatory changes relating to the insurance industry in the jurisdictions in which Aegon operates.

t  

Changes in customer behavior and public opinion in general related to, among other things, the type of products also Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations.

t  

Acts of God, acts of terrorism, acts of war and pandemics.

t  

Changes in the policies of central banks and/or governments.

t  

Lowering of one or more of Aegon’s debt ratings issued by recognized rating organizations and the adverse impact such action may have on Aegon’s ability to raise capital and on its liquidity and financial condition.

t  

Lowering of one or more of insurer financial strength ratings of Aegon’s insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability and liquidity of its insurance subsidiaries.

t  

The effect of the European Union’s Solvency II requirements and other regulations in other jurisdictions affecting the capital Aegon is required to maintain.

t  

Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does business.

t  

As Aegon’s operations support complex transactions and are highly dependent on the proper functioning of information technology, a computer system failure or security breach may disrupt Aegon’s business, damage its reputation and adversely affect its results of operations, financial condition and cash flows.

t  

Customer responsiveness to both new products and distribution channels.

t  

Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for Aegon’s products.

t  

Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies, voluntarily or otherwise, may affect Aegon’s reported results and shareholders’ equity.

t  

The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including Aegon’s ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions.

t  

Catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt Aegon’s business; and

t  

Aegon’s failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving initiatives.

Further details of potential risks and uncertainties affecting Aegon are described in its filings with the Netherlands Authority for the Financial Markets and the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, Aegon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Aegon’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

 

Unaudited    34


Table of Contents

LOGO

 

Corporate and shareholder information

 

Headquarters      
Aegon N.V.      
P.O. Box 85      
2501 CB The Hague      
The Netherlands      
Telephone    + 31(0) 70 344 32 10   
aegon.com      

Group Corporate Communications & Investor Relations

 

Media relations      
Telephone    + 31(0) 70 344 89 56   
E-mail    gcc@aegon.com   
Investor relations      
Telephone    + 31(0) 70 344 83 05   
   or 877 548 96 68 - toll free, USA only   
E-mail    ir@aegon.com   

Publication dates quarterly results

February 20, 2014    Results fourth quarter 2013   
May 15, 2014    Results first quarter 2014   
August 14, 2014    Results second quarter 2014   
November 13, 2014    Results third quarter 2014   

Aegon’s third quarter 2013 press release and Financial Supplement are available on aegon.com.

 

35    Unaudited


Table of Contents

LOGO

 

About Aegon

As an international life insurance, pensions and asset management company based in The Hague, Aegon has businesses in over 20 markets in the Americas, Europe and Asia. Aegon companies employ over 23,000 people and have millions of customers across the globe. Further information: aegon.com.